BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+19.16%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$817M
AUM Growth
+$817M
(+15%)
Cap. Flow
+$3.75M
Cap. Flow
% of AUM
0.46%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
2
Reduced
–
Closed
1
Top Buys
| 1 |
Lineage Cell Therapeutics
LCTX
|
$4.92M |
| 2 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$2.11M |
Top Sells
| 1 |
AST
Asterias Biotherapeutics Inc. Series A
AST
|
$3.28M |
Sector Composition
| 1 | Healthcare | 55.79% |
| 2 | Consumer Staples | 31.28% |
| 3 | Industrials | 5.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
STAAR Surgical
STAA
$1.36B
| $367M | 44.97% | 10,740,630 | – | – |
|
2
Monster Beverage
MNST
$60.9B
| $255M | 31.28% | 4,679,308 | – | – |
|
3
iShares Russell 2000 ETF
IWM
$67B
| $64.3M | 7.87% | 420,000 | – | – |
|
|
4
Lineage Cell Therapeutics
LCTX
$267M
| $44.2M | 5.41% | 33,728,991 +3,757,430 | +13% | +$4.92M |
|
5
Axon Enterprise
AXON
$58.7B
| $41.4M | 5.06% | 760,062 | – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $32M | 3.92% | 8,098,267 +533,333 | +7% | +$2.11M |
|
7
Serina Therapeutics
SER
$54.5M
| $12.1M | 1.49% | 2,997,156 | – | – |
|
|
AST
8
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| – | – | -5,292,156 | Closed | -$3.28M |
|